Lymphoma

>

Latest News

Graphic of blood cells
Fixed-Duration Mosunetuzumab/Polatuzumab Active in R/R MCL

September 22nd 2025

Off-the-shelf mosunetuzumab/polatuzumab vedotin produced durable responses with manageable safety in BTK inhibitor–exposed relapsed/refractory MCL.

Image of a lymphoma cell
Rx Road Map: Lisocabtagene Maraleucel for Mantle Cell Lymphoma

September 20th 2025

Image of lymphoma cells
Mosunetuzumab/Polatuzumab Vedotin Triples PFS in LBCL

September 17th 2025

Photo of a woman with blond hair wearing a white and black blazer
How to Manage ICANS in Patients With Hematologic Cancers

September 2nd 2025

Photo of a woman with blonde hair wearing a white and black blazer
Managing CRS in Hematologic Cancers: A Nursing Perspective

August 25th 2025

Video Interviews
Podcasts

More News

© 2025 MJH Life Sciences

All rights reserved.